查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584127

癌症護理市場中的基因組學，按測試類型、按技術類型、按應用、按最終用戶、按國家和地區分類 - 2024-2032年產業分析、市場規模、市場佔有率和預測

Genomics in Cancer Care Market, By Test Type, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，基因體學在癌症護理市場規模為1812,032萬美元，2024年至2032年年複合成長率為16.10%。

癌症護理市場中的基因組學-市場動態

對個人化醫療的日益重視推動基因組學在癌症護理市場的發展

對個人化醫療的日益重視顯著推動基因組學在癌症護理市場的發展，美國國家癌症研究所的研究結果證明，基於基因組分析的客製化治療可以改善超過 30%的癌症病例的患者預後。美國臨床腫瘤學會（ASCO）等組織主張將基因組資料整合到治療決策中，促進專門針對腫瘤基因突變的精準療法的開發。此外，大型舉措，例如美國國立衛生研究院的「All of Us Research Program」，目的是從不同人群收集廣泛的基因組資料，以更佳了解遺傳因素如何影響癌症和治療效果。因此，個人化醫療從概念轉變為實踐，基因組測試擴大在臨床環境中採用，以確定對個別患者最有效的治療方法，最終導向更好的癌症護理管理並提高生存率。

癌症護理市場中的基因組學 - 關鍵見解

根據研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 16.10%左右的年複合成長率成長

根據測試類型細分，預計種系基因組學測試將在2023年顯示最大的市場佔有率

根據技術類型細分，二代定序（NGS）是2023年的主導類型

根據應用細分，個人化醫療是2023年的主導類型

依地區分類，北美是2023年的主要收入來源

癌症護理市場中的基因組學 - 細分分析：

全球癌症護理市場基因組學根據測試類型、技術類型、應用、最終用戶和地區進行細分。

根據測試類型，市場分為兩類：種系基因組測試和體細胞基因組測試。種系基因組學測試因其在識別遺傳性癌症風險和告知預防策略方面的關鍵作用而排名最高。體細胞基因組學測試重點關注腫瘤特異性突變，為癌症護理中的個人化治療選擇提供重要見解。

根據技術類型，市場分為四類：次世代定序、PCR、微陣列和 CRISPR。新一代定序（NGS）擁有最高優先級，因為它能夠有效分析大量基因組資料。接下來是 PCR，廣泛用於標靶擴增。微陣列技術排名第三，而CRISPR雖然具有創新性，但在臨床應用中仍處於新興階段。

癌症護理市場中的基因組學 - 地理洞察

在先進的醫療基礎設施和研發方面的大量投資的推動下，北美在癌症護理市場的基因組學方面佔據主導地位。美國國家癌症研究所報告指出，基因組檢測可以指導近 50%癌症患者的治療，凸顯了其在精準醫療中的關鍵作用。歐洲緊隨其後，德國和英國等國家實施了強力的基因組醫學計劃，例如英國國民健康服務（NHS）基因組計畫，目的是將基因組測試納入超過 500萬名患者的常規癌症護理中。在亞太地區，中國和日本等國家正迅速採用基因組技術；中國「十三五」規劃強調發展生物技術，計畫加大對基因體研究和應用的投入。拉丁美洲逐步改善基因組檢測的可近性，巴西衛生部推動將基因組學納入癌症治療指南的措施。同時，中東和非洲正致力於加強醫療基礎設施以支持基因組醫學，這反映出人們越來越致力於透過創新的基因組方法來應對癌症。

癌症護理市場中的基因組學-競爭格局：

癌症護理市場基因組學的競爭格局主要由北美主導，Illumina 和 Thermo Fisher Scientific 等主要參與者推動創新。2023年，Illumina推出了Illumina NextSeq2000系統，顯著增強了癌症診斷和研究的基因組定序能力。在歐洲，Roche是一個強大的競爭對手，積極與各種醫療機構合作，將基因組測試整合到臨床實踐中，改善患者的治療結果。Roche與 Genomics England 計畫的合作目的是分析 10萬名癌症患者的基因組資料，為個人化治療策略鋪平道路。同時，在亞太地區，BGI Group取得顯著進展，開發了DNBSEQ平台來促進大規模基因組研究。此外，Illumina收購Grail也鞏固了其在早期癌症檢測市場的地位，利用液體活體組織切片技術提高診斷精度。這種競爭環境展示了利用基因組進步徹底改變全球癌症照護的承諾，透過合作和創新塑造腫瘤學的未來。

最新進展：

2024年 9月，印度癌症基因組圖譜（ICGA）最近推出了癌症多組學資料門戶，這是印度首個此類資料門戶。該入口網站提供乳癌患者資料的存取，包括他們的DNA、RNA 和蛋白質概況、治療歷史和患者結果。 ICGA 的目標是創建印度特有的資料集，以幫助研究人員和臨床醫生開發個人化的癌症治療方法。

2024年 9月，英國首個機器人基因組測試設施在Royal Marsden NHS Foundation Trust啟動，以加強癌症患者護理。這種自動化將使測試能力加倍，簡化流程，並透過識別遺傳風險和突變來改善獲得個人化治療的機會。

目錄

第1章 癌症護理市場中的基因組學概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依測試類型分類的癌症護理市場基因組學片段
    • 依技術類型分類的癌症護理市場基因組學片段
    • 依應用分類的癌症護理市場基因組學片段
    • 依最終用戶的癌症護理市場基因組學片段
    • 依國家/地區分類的癌症護理市場基因組學片段
    • 依地區分類的癌症護理市場基因組學片段
  • 競爭洞察

第3章 癌症治療中的基因組學主要市場趨勢

  • 癌症護理市場促進因素中的基因組學
    • 市場促進因素的影響分析
  • 癌症治療市場限制中的基因組學
    • 市場限制影響分析
  • 癌症護理市場機會中的基因組學
  • 癌症治療市場的基因組學未來趨勢

第4章 癌症護理產業研究中的基因組學

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 癌症護理市場中的基因組學：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 癌症護理市場格局中的基因組學

  • 癌症護理市場佔有率分析中的基因組學，2023年
  • 依主要製造商分類的細分資料
    • 既有參與者分析
    • 新興參與者分析

第7章 癌症護理市場中的基因組學 - 依測試類型

  • 概述
    • 依測試類型分類的細分市場佔有率分析
    • 種系基因組學測試
    • 體細胞基因體學檢測

第8章 癌症護理市場中的基因組學 - 依技術類型

  • 概述
    • 依技術類型分類的細分市場佔有率分析
    • 新一代定序（NGS）
    • 聚合酶鍊式反應
    • 微陣列
    • 基因編輯技術

第9章 癌症護理市場中的基因組學 - 依應用

  • 概述
    • 依應用分類的細分市場佔有率分析
    • 生物標記發現
    • 個人化醫療
    • 藥物發現與開發
    • 臨床診斷

第10章 癌症護理市場中的基因組學 - 依最終用戶

  • 概述
    • 依最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診斷實驗室
    • 研究所
    • 製藥與生物技術公司

第11章 癌症護理市場中的基因組學 - 依地理位置

  • 介紹
    • 依地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 癌症護理中的基因組學北美主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依測試類型）
    • 北美市場規模和預測（依技術類型）
    • 北美市場規模和預測（依應用）
    • 北美市場規模和預測（依最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 癌症治療中的基因組學歐洲主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依測試類型）
    • 歐洲市場規模和預測（依技術類型）
    • 歐洲市場規模和預測（依應用）
    • 歐洲市場規模和預測（依最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 癌症治療中的基因組學亞太地區主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模和預測（依測試類型）
    • 亞太地區市場規模與預測（依技術類型）
    • 亞太地區市場規模與預測（依應用）
    • 亞太地區市場規模和預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 癌症護理中的基因組學拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模和預測（依測試類型）
    • 拉丁美洲市場規模與預測（依技術類型）
    • 拉丁美洲市場規模與預測（依應用）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 癌症治療中的基因組學 中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依測試類型）
    • 中東和非洲市場規模及預測（依技術類型）
    • 中東和非洲市場規模及預測（依應用）
    • 中東和非洲市場規模和預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA其他

第12章 關鍵供應商分析 - 癌症護理產業中的基因組學

  • 競爭儀表板
  • 公司簡介
    • Adaptive Biotechnologies Corporation
    • Agilent Technologies, Inc.
    • BGI Group
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Foundation Medicine, Inc.（Roche）
    • Genomic Health, Inc.（Exact Sciences）
    • Guardant Health, Inc.
    • Illumina, Inc.
    • Myriad Genetics, Inc.
    • NeoGenomics, Inc.
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
    • Others

第13章 360 度分析師視角

第14章 附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4110

REPORT HIGHLIGHT

Genomics in Cancer Care Market size was valued at USD 18,120.32 Million in 2023, expanding at a CAGR of 16.10% from 2024 to 2032.

The Genomics in Cancer Care Market encompasses the application of genomic technologies to enhance cancer diagnosis, treatment, and prevention strategies. With the increasing understanding of the genetic basis of cancer, there is a growing emphasis on personalized medicine, which has led to significant advancements in genomics. A report from the National Cancer Institute indicated that genomic testing could improve treatment outcomes for over 40% of cancer patients by identifying specific mutations. The rising prevalence of cancer globally, coupled with the growing demand for precision therapies, is boosting market growth. However, challenges such as high costs associated with genomic testing and a lack of standardized guidelines may restrain widespread adoption. Additionally, ethical concerns surrounding genetic data usage present barriers to market expansion. Opportunities are emerging in the development of innovative genomic technologies, such as liquid biopsies and next-generation sequencing, which are transforming cancer diagnostics and treatment approaches. These advancements are expected to enhance patient outcomes and drive the future of cancer care.

Genomics in Cancer Care Market- Market Dynamics

Growing Emphasis on Personalized Medicine Propels the Genomics in Cancer Care Market

The growing emphasis on personalized medicine is significantly propelling the Genomics in Cancer Care Market, as evidenced by the National Cancer Institute's findings that tailored treatments based on genomic profiling can improve patient outcomes in over 30% of cancer cases. Organizations like the American Society of Clinical Oncology (ASCO) advocate for the integration of genomic data in treatment decision-making, promoting the development of precision therapies that specifically target genetic mutations in tumors. Additionally, large-scale initiatives, such as the All of Us Research Program by the National Institutes of Health, aim to gather extensive genomic data from diverse populations to better understand how genetic factors influence cancer and treatment efficacy. As a result, personalized medicine is transitioning from concept to practice, with genomic tests being increasingly adopted in clinical settings to identify the most effective treatments for individual patients, ultimately leading to better management of cancer care and improved survival rates.

Genomics in Cancer Care Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.10% over the forecast period (2024-2032)

Based on Test Type segmentation, Germline genomics testing was predicted to show maximum market share in the year 2023

Based on Technology Type segmentation, Next-Generation Sequencing (NGS) was the leading type in 2023

Based on Application segmentation, Personalized Medicine was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomics in Cancer Care Market- Segmentation Analysis:

The Global Genomics in Cancer Care Market is segmented on the basis of Test Type, Technology Type, Application, End-User, and Region.

The market is divided into two categories based on Test Type: Germline Genomics Testing, and Somatic Genomics Testing. Germline genomics testing ranks highest due to its critical role in identifying hereditary cancer risks and informing prevention strategies. Somatic genomics testing follows as it focuses on tumor-specific mutations, providing essential insights for personalized treatment options in cancer care.

The market is divided into four categories based on Technology Type: Next-Generation Sequencing, PCR, Microarray, and CRISPR. Next-Generation Sequencing (NGS) holds the highest priority due to its ability to analyze vast amounts of genomic data efficiently. PCR follows, widely used for targeted amplification. Microarray technology ranks third, while CRISPR, although innovative, is still emerging in clinical applications.

Genomics in Cancer Care Market- Geographical Insights

North America dominates the Genomics in Cancer Care Market, driven by advanced healthcare infrastructure and significant investments in research and development. The U.S. National Cancer Institute reported that genomic testing could guide treatment for nearly 50% of cancer patients, highlighting its critical role in precision medicine. Europe follows closely, with countries like Germany and the UK implementing robust genomic medicine initiatives, such as the Genomic UK National Health Service (NHS) project, aiming to integrate genomic testing into routine cancer care for over 5 million patients. In the Asia-Pacific region, countries like China and Japan are rapidly adopting genomic technologies; China's 13th Five-Year Plan emphasizes the development of biotechnology, with plans to increase investment in genomic research and application. Latin America is gradually improving access to genomic testing, with Brazil's Ministry of Health promoting initiatives to incorporate genomics into cancer treatment guidelines. Meanwhile, the Middle East & Africa are focusing on enhancing healthcare infrastructure to support genomic medicine, reflecting a growing commitment to tackling cancer through innovative genomic approaches.

Genomics in Cancer Care Market- Competitive Landscape:

The competitive landscape of the Genomics in Cancer Care Market is primarily led by North America, with key players like Illumina and Thermo Fisher Scientific driving innovation. In 2023, Illumina launched its Illumina NextSeq 2000 system, which significantly enhances genomic sequencing capabilities for cancer diagnostics and research. In Europe, Roche is a formidable competitor, actively collaborating with various healthcare institutions to integrate genomic testing into clinical practices, thus improving patient outcomes. Roche's partnership with the Genomics England initiative aims to analyze genomic data from 100,000 cancer patients, paving the way for personalized treatment strategies. Meanwhile, in the Asia-Pacific region, BGI Group is making notable advancements, having developed the DNBSEQ platform to facilitate large-scale genomic studies. Additionally, the acquisition of Grail by Illumina has reinforced its position in the early cancer detection market, utilizing liquid biopsy technology to enhance diagnostic precision. This competitive environment showcases a commitment to leveraging genomic advancements to revolutionize cancer care globally, with collaborations and innovations shaping the future of oncology.

Recent Developments:

In September 2024, The Indian Cancer Genome Atlas (ICGA) recently launched a multi-omics data portal for cancer, which is the first of its kind in India. The portal provides access to data on breast cancer patients, including their DNA, RNA, and protein profiles, treatment histories, and patient outcomes. The ICGA's goal is to create datasets specific to India to help researchers and clinicians develop personalized cancer treatments.

In September 2024, The UK's first robotic genomic testing facility was launched at The Royal Marsden NHS Foundation Trust, enhancing cancer patient care. This automation will double testing capacity, streamline processes, and improve access to personalized treatments by identifying genetic risks and mutations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMICS IN CANCER CARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc. (Roche)
  • Genomic Health, Inc. (Exact Sciences)
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Germline Genomics Testing
  • Somatic Genomics Testing

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • PCR
  • Microarray
  • CRISPR

GLOBAL GENOMICS IN CANCER CARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biomarker Discovery
  • Personalized Medicine
  • Drug Discovery & Development
  • Clinical Diagnostics

GLOBAL GENOMICS IN CANCER CARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMICS IN CANCER CARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomics in Cancer Care Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomics in Cancer Care Market Snippet by Test Type
    • 2.1.2. Genomics in Cancer Care Market Snippet by Technology Type
    • 2.1.3. Genomics in Cancer Care Market Snippet by Application
    • 2.1.4. Genomics in Cancer Care Market Snippet by End-User
    • 2.1.5. Genomics in Cancer Care Market Snippet by Country
    • 2.1.6. Genomics in Cancer Care Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomics in Cancer Care Key Market Trends

  • 3.1. Genomics in Cancer Care Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomics in Cancer Care Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomics in Cancer Care Market Opportunities
  • 3.4. Genomics in Cancer Care Market Future Trends

4. Genomics in Cancer Care Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomics in Cancer Care Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomics in Cancer Care Market Landscape

  • 6.1. Genomics in Cancer Care Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomics in Cancer Care Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Germline Genomics Testing
    • 7.1.3. Somatic Genomics Testing

8. Genomics in Cancer Care Market - By Technology Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. PCR
    • 8.1.4. Microarray
    • 8.1.5. CRISPR

9. Genomics in Cancer Care Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Biomarker Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Drug Discovery & Development
    • 9.1.5. Clinical Diagnostics

10. Genomics in Cancer Care Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes
    • 10.1.5. Pharmaceutical & Biotechnology Companies

11. Genomics in Cancer Care Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomics in Cancer Care Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomics in Cancer Care Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomics in Cancer Care Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomics in Cancer Care Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomics in Cancer Care Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomics in Cancer Care Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. BGI Group
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. F. Hoffmann-La Roche AG
    • 12.2.6. Foundation Medicine, Inc. (Roche)
    • 12.2.7. Genomic Health, Inc. (Exact Sciences)
    • 12.2.8. Guardant Health, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Myriad Genetics, Inc.
    • 12.2.11. NeoGenomics, Inc.
    • 12.2.12. Oxford Nanopore Technologies Ltd.
    • 12.2.13. Pacific Biosciences of California, Inc.
    • 12.2.14. PerkinElmer, Inc.
    • 12.2.15. Qiagen N.V.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us